Drug Type Small molecule drug |
Synonyms AV 965, AV965 |
Target |
Action antagonists |
Mechanism 5-HT1A receptor antagonists(Serotonin 1a (5-HT1a) receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 1 | United States | - | - |
Alzheimer Disease | Phase 1 | - | - | |
Cognition Disorders | Phase 1 | United States | - | - |
Cognition Disorders | Phase 1 | - | - |